The much-anticipated 89th China International Medical Equipment Fair (CMEF) was officially launched on April 11th, 2024 at the National Convention and Exhibition Center (Shanghai).
Nearly 5,000 companies from all over the world gathered in the Magic City. BIOELAB has participated in CMEF for many years, sharing innovative technology achievements with the world, sharing Chinese solutions, and showing " the light of products made in China " of IVD.
At Booth U01 in Hall 6.1, BIOELAB made a shocking appearance with a number of cutting-edge products covering chemistry, hematology, coagulation, luminescence and other in vitro diagnostic fields.
BIOELAB has always been insisting on human-centered product research and development, in order to make in vitro diagnostic technology benefit more people and benefit the cause of human health. In this exhibition, BIOELAB demonstrated its innovative " hard power " and also emphasized on user experience, demonstrated the product on-site, and carefully captured the unique concepts of users on the health diagnosis of the products.
On the scene, BIOELAB 's novel design, exquisite skills and excellent quality attracted many professional visitors to stop and discuss, and the sales team matched customer needs with product strengths. Both sides actively explored and discussed insights to seize the future of the industry. The exhibition further enhanced the influence and popularity of BIOELAB, which was very fruitful.
BIOELAB integrates R&D, design, production and sales of collective diagnostic medical devices, which possesses professional and efficient R&D strength. Facing with the changing market condition, the company focuses on its core R&D strength, continuously improves the value of its products, and establishes long-term cooperative relationships with many domestic and foreign enterprises and medical institutions due to the practicality and reliability of the products, which develops for the benefit of global human health.
In 2024, BIOELAB will launch four " star " products.
The first fully automatic chemiluminescence immunoassay analyzer IA-200 has the fastest analysis speed of 200 T/H, with a first report of 14min, online reagent replacement, and uninterrupted loading of samples, which is the best choice for emergency treatment.
Fully automatic coagulation analyzer CL-600 adopts light source dynamic enhancement technology, the instrument can select the optimal detection wavelength according to the sample status, intelligent anti-interference, high sensitivity.
Fully automatic 5-diff hematology analyzer EC-51 speed up to 60 tests/hour, 15μL blood, focusing on micro-volume blood testing, simplified, reliable application.
Fully automatic chemical analyzer BT-330 speed up to 330 tests/hour for double reagent with liquid level detection, volume tracking, vertical anti-collision, and needle blocking detection, which is the best choice for speed and efficiency.
In the new journey, the road ahead is still long. BIOELAB will continue to plow through the core technology innovation at the source, and join hands with the industry partners with an open mind to promote the scientific and technological innovation results to the ground, so as to benefit more patients.
